Markets:

Overview

News

Currencies

International

Treasuries

Sagimet Biosciences Inc. - Series A Common Stock (NQ:SGMT)

5.050 +0.430 (+9.31%)

Streaming Delayed Price Updated: 2:51 PM EDT, Mar 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Sagimet Biosciences Inc. - Series A Common Stock

< Previous 1 2 3 4 5 Next >

Sagimet Biosciences Announces Pricing of Public Offering of Series A Common Stock

January 25, 2024

From Sagimet Biosciences Inc.

Via GlobeNewswire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

January 24, 2024

It's time to dive into the biggest pre-market stock movers on Tuesday with a breakdown of all the latest news affecting shares this morning.

Via InvestorPlace

Texas Instruments Reports Q4 Results, Joins BlackBerry And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

January 24, 2024

U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 100 points on Wednesday.

Via Benzinga

Sagimet Biosciences Announces Proposed Public Offering of Series A Common Stock

January 23, 2024

From Sagimet Biosciences Inc.

Via GlobeNewswire

Why 3M Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 23, 2024

Shares of 3M Company (NYSE: MMM) fell sharply during Tuesday’s session after the company reported better-than-expected fourth-quarter EPS, but issued FY24 EPS guidance below estimates.

Via Benzinga

Why United Airlines Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket ↗

January 23, 2024

Shares of United Airlines Holdings, Inc. (NASDAQ: UAL) shares rose in today’s pre-market trading as the company reported better-than-expected financial results for its fourth quarter.

Via Benzinga

Logitech Posts Q3 Results, Joins Coinbase And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

January 23, 2024

U.S. stock futures were mostly lower this morning, with the Dow futures falling around 20 points on Tuesday.

Via Benzinga

Topics Stocks

Dow Gains Over 100 Points; Archer-Daniels-Midland Shares Plunge ↗

January 22, 2024

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Monday. The Dow traded up 0.27% to 37,967.81 while the NASDAQ rose 0.31% to 15,358.70. The...

Via Benzinga

Topics Stocks

Why CommScope Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

January 22, 2024

Shares of CommScope Holding Company, Inc. (NASDAQ: COMM) fell sharply during Monday’s session. B of A Securities analyst Tal Liani downgraded CommScope from Neutral to Underperform and lowered the...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

January 22, 2024

Via Benzinga

Crude Oil Surges Over 2%; US Leading Economic Index Falls In December ↗

January 22, 2024

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 150 points on Monday. The Dow traded up 0.41% to 38,018.23 while the NASDAQ rose 0.30% to 15,356.67. The S&P...

Via Benzinga

Topics Stocks

NuStar Energy, Spirit Airlines, Fastly And Other Big Stocks Moving Higher On Monday ↗

January 22, 2024

U.S. stocks traded higher, with the Dow Jones index gaining around 200 points on Monday. Shares of NuStar Energy L.P. (NYSE: NS) rose sharply during Monday’s session after Sunoco announced it will...

Via Benzinga

Topics Stocks

Why Is Fatty Liver Disease Focused Sagimet Biosciences Stock Shooting Higher Today? ↗

January 22, 2024

Sagimet Biosciences reports positive results from FASCINATE-2 Phase 2b trial. Denifanstat demonstrates significant improvements in NASH patients with fibrosis at week 52.

Via Benzinga

US Stocks Higher; Nasdaq Jumps 100 Points ↗

January 22, 2024

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 100 points on Monday. Following the market opening Monday, the Dow traded up 0.55% to 38,073.10 while the NASDAQ rose...

Via Benzinga

Topics Stocks

Sagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASH

January 22, 2024

From Sagimet Biosciences Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

January 11, 2024

Via Benzinga

Why TechTarget Shares Are Trading Higher By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

January 11, 2024

Shares of TechTarget, Inc. (NASDAQ: TTGT) rose sharply during Thursday’s session after the company announced a strategic combination with Informa Tech's digital businesses. TechTarget shares surged...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 11, 2024

Via Benzinga

Sagimet Biosciences to Participate in the First Annual Goldman Sachs Catalyst Clinic

December 04, 2023

From Sagimet Biosciences Inc.

Via GlobeNewswire

Sagimet Biosciences Announces Oral Presentation of Preclinical Results of FASN Inhibitor in Combination with Semaglutide at the 7th Obesity and NASH Drug Development Summit

November 28, 2023

From Sagimet Biosciences Inc.

Via GlobeNewswire

Sagimet Biosciences to Present at the 35th Annual Piper Sandler Healthcare Conference

November 22, 2023

From Sagimet Biosciences Inc.

Via GlobeNewswire

Sagimet Biosciences Reports Third Quarter 2023 Financial Results and Provides Corporate Updates

November 13, 2023

From Sagimet Biosciences Inc.

Via GlobeNewswire

Sagimet Biosciences Announces Acceptance of Two Abstracts at AASLD - The Liver Meeting® 2023

October 24, 2023

From Sagimet Biosciences Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 20, 2023

Via Benzinga

Sagimet Biosciences To Present at the H.C. Wainwright 7th Annual NASH Investor Conference

October 18, 2023

From Sagimet Biosciences Inc.

Via GlobeNewswire

Sagimet Biosciences Announces Completion of Enrollment of 120 Patients for Phase 3 Clinical Trial by Its Partner Ascletis of Denifanstat Combined with Bevacizumab for Treatment of Recurrent Glioblastoma

September 27, 2023

From Sagimet Biosciences Inc.

Via GlobeNewswire

Stocks That Hit 52-Week Lows On Thursday ↗

October 05, 2023

On Thursday, 369 companies hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

October 02, 2023

On Monday, 369 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

August 23, 2023

Wednesday's session saw 150 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

September 26, 2023

On Tuesday, 386 stocks made new 52-week lows.

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.